Despite the multiple proposed physiological roles of guanylin peptides and increased interest in their use for treating irritable bowel syndrome or colorectal cancer33, the cellular origins of guanylin and the mechanisms underlying its secretion are poorly understood. This evidence concerns the gene GUCA2A and irritable bowel syndrome.